Trial intelligence / Profile preview

Combination vs Monotherapy Antibiotics for COPD Exacerbations

NCT04879030Phase 3Completed

Sponsor
Hai Phong University of Medicine and Pharmacy
Start
Jan 2020
Primary completion
Aug 2020
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of ciprofloxacin, levofloxacin, moxifloxacin in chronic obstructive pulmonary disease (COPD), sponsored by Hai Phong University of Medicine and Pharmacy. Started Jan 2020; status: completed.

02

Drugs

ciprofloxacinlevofloxacinmoxifloxacin
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT04879030.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04879030.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call